Orbsen Therapeutics Limited is a leading company in the development of regenerative medicine therapies across a range of diseases and medical conditions. Formed in 2006 as a spin out from Ireland’s Regenerative Medicine Institute (REMEDI), Orbsen has since developed proprietary technologies focused on the isolation of pure and defined stromal cells. Headed by some of the world’s most prominent scientists in the field of regenerative medicine, Orbsen Therapeutics is headquartered on campus at NUI Galway, operating out of the Orbsen Building, which also houses REMEDI’s state-of-the-art GMP facility. Our offices have beautiful views overlooking Lough Corrib, which in ancient times was called Lough Orbsen, thus our company name.

Leadership

Dr. Larry A. Couture

Chief Executive Officer

Dr. Couture’s recognized expertise–established over nearly three decades of work with experimental biologics, heavily focused on cell and gene therapies–includes organizational management, regulatory affairs, business development, process development, GMP manufacturing and clinical development.

Read More

Dr. Stephen Elliman

Chief Scientific Officer

With over 13 years’ experience in stromal cell medicine, Steve Elliman is Chief Scientific Officer at Orbsen Therapeutics Ltd. Steve’s aim to develop effective cell therapies began during his PhD studies, where he worked to initially describe and define marrow derived mesenchymal stromal cells.

Read More

Board of Directors

Dr. Jack Kavanaugh

Chairman of the Board

Dr Kavanaugh’s background as a physician and a business executive has led to the development of an unusual skill set. That, coupled with a talent for discerning what’s truly innovative and an ability to accurately gauge the commercial potential of a given research project, start-up or company, has resulted in an impressive array of business accomplishments.

Read More

Dr. Larry A. Couture

Chief Executive Officer

Dr. Couture’s recognized expertise–established over nearly three decades of work with experimental biologics, heavily focused on cell and gene therapies–includes organizational management, regulatory affairs, business development, process development, GMP manufacturing and clinical development.

Read More

Prof Frank Barry

Scientific Founder and Director

Professor Barry has served as Director of Arthritis Research and Associate Director of Cartilage Research and Analytical Biochemistry at Osiris Therapeutics Inc., Baltimore, and previously as Assistant Professor, Dept Biochemistry and Molecular Biology, University of South Florida College of Medicine, Tampa.

Read More

Prof Timothy O’Brien

Scientific Founder and Director

Professor O’Brien is Consultant Endocrinologist at Galway University Hospital, having previously worked as a Consultant in the Division of Endocrinology, Nutrition and Metabolism at the Mayo Clinic, Rochester, USA.

Read More

James F.X. Fahy

Founding Director

James (Jim) Fahy is a lawyer based in Minnesota, USA. A native of Galway, he obtained a BA in Political Science from DePaul University and a JD from Loyola University, Chicago School of Law.

Read More

Gerry Cuddy

Director

Gerry Cuddy is the Founding Director with HC Financial Advisers, having established the company in 1988. Gerry is a Fellow of the Chartered Association of Certified Accountants and a member of the Sales Institute of Ireland.

Read More

Dr. Chris Coughlan

Founding Director

Chris is a member of the senior management team of a leading US multinational company in the information technology sector in Galway. His responsibilities include leading a R&D team specialising in information management. He has a number of patents filed in this area.

Read More